Literature DB >> 89892

Relationship of hepatitis B surface antigen to serum alpha-fetoprotein in nonmalignant diseases of the liver.

D S Chen, J L Sung.   

Abstract

Serum alpha-fetoprotein (AFP) levels were measured by radioimmunoassay in 89 healthy adult Chinese, 170 patients with histologically verified non-malignant liver diseases, and 14 hepatitis B surface antigen (HBsAg) carriers with normal liver histology. In 97% of the healthy adults, AFP levels were under 20 ng/ml, which is then regarded as the normal upper limit. Cases with supranormally elevated AFP levels ranged from 15-51% in chronic hepatic disorders and were 33% in acute hepatitis. None of the healthy HBsAg carriers had abnormal AFP level. HBs antigenemia was found to be related to AFP elevation in chronic active hepatitis, cirrhosis, and acute hepatitis but not in chronic persistent hepatitis and healthy HBsAg carriers. The correlation could be demonstrated only when the sensitive third generation test was employed to define seropositivity of HBsAg. Events after hepatic injury induced by hepatitis B virus, rather than the HBs antigenemia itself, are probably responsible for the association. Whether the association of HBsAg and elevated serum AFP in these nonmalignant hepatic disorders contributes to the higher risk of subsequent development of hepatocarcinoma in Taiwan is unknown and requires further long-term longitudinal study.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 89892     DOI: 10.1002/1097-0142(197909)44:3<984::aid-cncr2820440328>3.0.co;2-6

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  9 in total

1.  Immunoelectron microscopic observation of alpha-fetoprotein synthesis in human non-malignant liver tissues using immunoperoxidase methods.

Authors:  S Kinoyama; G Yamada; H Okushin; H Mimura; T Kobayashi; T Tsuji
Journal:  Gastroenterol Jpn       Date:  1988-08

2.  Differentiation of acute and chronic hepatitis B in IgM anti-HBc positive patients.

Authors:  Ji Won Park; Kyeong Min Kwak; Sung Eun Kim; Myoung Kuk Jang; Dong Joon Kim; Myung Seok Lee; Hyoung Su Kim; Choong Kee Park
Journal:  World J Gastroenterol       Date:  2015-04-07       Impact factor: 5.742

3.  The triad of lichen planus, thymoma and liver cirrhosis-hepatoma. First reported case.

Authors:  J A Hassan; S Saadiah; A M Roslina; M Atan; N Masir; S Hussein; T Ganesapillai
Journal:  Malays J Med Sci       Date:  2000-07

4.  Relationship of serum alpha-fetoprotein to circulating immune complexes and complements in patients with hepatitis B surface antigen-positive hepatocellular carcinoma.

Authors:  J F Tsai; J H Tsai; W Y Chang
Journal:  Gastroenterol Jpn       Date:  1990-06

5.  AFP-specific CD4+ helper T-cell responses in healthy donors and HCC patients.

Authors:  Viktoria N Evdokimova; Yang Liu; Douglas M Potter; Lisa H Butterfield
Journal:  J Immunother       Date:  2007 May-Jun       Impact factor: 4.456

6.  Influence of Alanine Transaminase Levels on Alpha-Fetoprotein for Predicting Hepatocellular Carcinoma in Patients with Hepatitis B Infection.

Authors:  Jiahao Chen; Manli Wu; Jiao Gong; Zhihuan Liu; Guowei He; Huiqing Zhu; Zhaoxia Li; Bo Hu
Journal:  Biomed Res Int       Date:  2020-12-15       Impact factor: 3.411

7.  A comparison of clinical pathologic characteristics between alpha-fetoprotein negative and positive hepatocellular carcinoma patients from Eastern and Southern China.

Authors:  Xiaowei Chi; Liejun Jiang; Yulin Yuan; Xinyan Huang; Xuemei Yang; Steven Hochwald; Jie Liu; Huayi Huang
Journal:  BMC Gastroenterol       Date:  2022-04-23       Impact factor: 2.847

8.  Idiopathic portal hypertension in an "inactive" HBV carrier: a case report.

Authors:  Themistoklis G Vassiliadis; Anthia Gatopoulou; Kaliopi Patsiaoura; Olga Giouleme; Konstantinos Soufleris; Alexandros Boubonaris; Panagiotis Katsinelos; Nikolaos Eugenidis
Journal:  Cases J       Date:  2008-10-08

9.  Frequency of raised alpha-fetoprotein level among Chinese patients with hepatocellular carcinoma related to hepatitis B and C.

Authors:  J F Tsai; W Y Chang; J E Jeng; M S Ho; Z Y Lin; J H Tsai
Journal:  Br J Cancer       Date:  1994-06       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.